Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lan G Coffman

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Cancer Research|August 31, 2011
An iron regulatory gene signature predicts outcome in breast cancerLance D Miller, Lan G Coffman, Jeff W Chou, et al.
Cell Reports|July 27, 2024
Carcinoma-associated mesenchymal stem cells promote ovarian cancer heterogeneity and metastasis through mitochondrial transferLeonard Frisbie, Catherine Pressimone, Emma Dyer, et al.
Cancer Cell|October 11, 2024
The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactionsIan P MacFawn, Grant Magnon, Grace Gorecki, et al.
Science Advances|November 12, 2021
Cancer-associated MSC drive tumor immune exclusion and resistance to immunotherapy, which can be overcome by Hedgehog inhibitionSandra Cascio, Chelsea Chandler, Linan Zhang, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 15, 2008
Cleavage of high-molecular-weight kininogen by elastase and tryptase is inhibited by ferritinLan G Coffman, Julie C Brown, David A Johnson, et al.
Cancers|February 10, 2024
Genetically Engineered Probiotic <i>Limosilactobacillus reuteri</i> Releasing IL-22 (LR-IL-22) Modifies the Tumor Microenvironment, Enabling Irradiation in Ovarian CancerDiala F Hamade, Michael W Epperly, Renee Fisher, et al.
Cell Reports|December 9, 2020
Epigenomic Reprogramming toward Mesenchymal-Epithelial Transition in Ovarian-Cancer-Associated Mesenchymal Stem Cells Drives MetastasisHuihui Fan, Huda I Atiya, Yeh Wang, et al.
JCI Insight|August 16, 2022
Phase I trial of ribociclib with platinum chemotherapy in ovarian cancerLan G Coffman, Taylor J Orellana, Tianshi Liu, et al.
Nature Communications|June 8, 2021
B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinomaAyana T Ruffin, Anthony R Cillo, Tracy Tabib, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
RHOV is a Detachment-Responsive Rho GTPase Necessary for Ovarian Cancer Peritoneal MetastasisAmal T Elhaw, Priscilla W Tang, Ya-Yun Cheng, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Cancer Research|August 31, 2011
An iron regulatory gene signature predicts outcome in breast cancerLance D Miller, Lan G Coffman, Jeff W Chou, et al.
Cell Reports|July 27, 2024
Carcinoma-associated mesenchymal stem cells promote ovarian cancer heterogeneity and metastasis through mitochondrial transferLeonard Frisbie, Catherine Pressimone, Emma Dyer, et al.
Cancer Cell|October 11, 2024
The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactionsIan P MacFawn, Grant Magnon, Grace Gorecki, et al.
Science Advances|November 12, 2021
Cancer-associated MSC drive tumor immune exclusion and resistance to immunotherapy, which can be overcome by Hedgehog inhibitionSandra Cascio, Chelsea Chandler, Linan Zhang, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 15, 2008
Cleavage of high-molecular-weight kininogen by elastase and tryptase is inhibited by ferritinLan G Coffman, Julie C Brown, David A Johnson, et al.
Cancers|February 10, 2024
Genetically Engineered Probiotic <i>Limosilactobacillus reuteri</i> Releasing IL-22 (LR-IL-22) Modifies the Tumor Microenvironment, Enabling Irradiation in Ovarian CancerDiala F Hamade, Michael W Epperly, Renee Fisher, et al.
Cell Reports|December 9, 2020
Epigenomic Reprogramming toward Mesenchymal-Epithelial Transition in Ovarian-Cancer-Associated Mesenchymal Stem Cells Drives MetastasisHuihui Fan, Huda I Atiya, Yeh Wang, et al.
JCI Insight|August 16, 2022
Phase I trial of ribociclib with platinum chemotherapy in ovarian cancerLan G Coffman, Taylor J Orellana, Tianshi Liu, et al.
Nature Communications|June 8, 2021
B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinomaAyana T Ruffin, Anthony R Cillo, Tracy Tabib, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
RHOV is a Detachment-Responsive Rho GTPase Necessary for Ovarian Cancer Peritoneal MetastasisAmal T Elhaw, Priscilla W Tang, Ya-Yun Cheng, et al.
Pageof 3